Merkel cell carcinoma (MCC) is one of the fastest-growing skin cancers. In a study of 195 patients, 63% of tumors had visibly expanded in the three months before diagnosis, often doubling in size over just a few weeks. Unlike melanoma or basal cell carcinoma, which can take months or years to become noticeable, MCC tends to appear suddenly and enlarge quickly enough that patients and doctors can observe changes in real time.
How Quickly MCC Typically Appears and Expands
Most people with MCC describe a firm, painless bump that seemed to come from nowhere and grew rapidly. The tumor usually shows up on sun-exposed skin, particularly the face, neck, or arms, and it often looks like a dome-shaped red or pink nodule. What makes MCC distinctive is the speed: a lesion that was barely noticeable can become a marble-sized lump within weeks.
Despite this rapid growth, 88% of MCC tumors are painless, which is part of why people sometimes wait before seeking care. A fast-growing but nontender bump is easy to dismiss as a cyst, bug bite, or other harmless skin change. In fact, up to 56% of MCC lesions are thought to be benign at the time they’re first biopsied. That combination of aggressive growth and innocent appearance is what makes early recognition so important.
Why MCC Grows So Aggressively
About 80% of MCC tumors are driven by a virus called Merkel cell polyomavirus. Once this virus integrates into a cell’s DNA, it produces proteins that hijack two of the body’s most important brakes on cell growth. One viral protein disables a tumor suppressor called RB, which normally prevents cells from dividing when they shouldn’t. With RB out of the way, cells enter their growth phase without any checkpoint to stop them.
A second viral protein amplifies the damage by ramping up production of molecules that break down p53, another key tumor suppressor. In healthy cells, p53 acts as a last line of defense: if a cell is dividing abnormally, p53 triggers its self-destruction. By promoting p53 degradation, the virus essentially removes the cell’s ability to recognize that something has gone wrong. The result is rapid, unchecked proliferation, which explains why MCC tumors can grow so much faster than most other skin cancers.
The AEIOU Warning Signs
Dermatologists use the acronym AEIOU to describe the features most common in MCC at the time of diagnosis:
- Asymptomatic (painless)
- Expanding rapidly
- Immunosuppression (weakened immune system)
- Older than 50
- UV-exposed skin (fair-skinned individual)
Not every patient checks all five boxes, but the combination of a painless, fast-growing bump on sun-exposed skin in someone over 50 is the classic pattern. If a new skin lump doubles in size over a few weeks and doesn’t hurt, that alone warrants a biopsy rather than a wait-and-see approach.
How Timing Affects Outcomes
Because MCC grows quickly, the stage at diagnosis has a major impact on survival. According to the American Cancer Society, five-year relative survival rates based on data from 2015 to 2021 break down as follows:
- Localized (confined to the skin): 79%
- Regional (spread to nearby lymph nodes): 66%
- Distant (spread to other organs): 31%
The gap between localized and distant disease is stark, and MCC can bridge that gap in a matter of months. A tumor that starts as a small nodule can involve nearby lymph nodes surprisingly quickly, which is why treatment timelines for MCC are compressed compared to many other cancers.
How MCC Compares to Other Skin Cancers
MCC is rare, with about 3,000 new diagnoses in the United States each year, but it is significantly more aggressive than the common skin cancers most people know. Basal cell carcinoma, the most common type, grows slowly and almost never spreads beyond the skin. Melanoma is considered fast-growing when it expands more than half a millimeter per month. MCC routinely outpaces both.
The recurrence rate further illustrates how aggressive this cancer is. In a study of 208 patients, 42% experienced a recurrence, and the median time to that first recurrence was just eight months after initial treatment. Most recurrences happen within the first two years, which is why follow-up during that window tends to be frequent and thorough.
What This Means in Practical Terms
If you have a new skin bump that is growing noticeably over days to weeks, is firm and painless, and is on a part of your body that gets regular sun exposure, getting it evaluated promptly matters more than it would for a slow-growing lesion. MCC’s speed is what makes it dangerous, but it is also the feature that should prompt action. A lump that appeared three weeks ago and has already doubled in size is not behaving like a cyst or a pimple, and a biopsy can quickly clarify what’s going on.
For people already diagnosed, the rapid growth rate is also why treatment planning tends to move fast. The difference between localized and regional disease can be a matter of weeks, and catching MCC before it reaches the lymph nodes substantially improves the odds.